|
DESCRIPTION
AUROgel (sodium hyaluronate 1.4%) ophthalmic viscosurgical device is a cohesive
viscoelastic formulation. It is characterized by high molecular weight, high pseudoplasticity,
and high surface tension. It provides excellent space maintenance, facilitates IOL implantation,
and is easily removed.
PROPERTIES
Molecular weight 1.1-2 million Daltons
Viscosity 20000-80000 mPa.s
Osmolality 270-400 mOsmol/Kg
pH 6.8 to 7.4
CHARACTERISTICS
Controlled capsulorrhexis.
Easy implantation
Better adhesiveness on the corneal endothelium during phacoemulsification.
Favourable environment to ophthalmic surgery.
Excellent protection against mechanical damages.
Steam sterilized
Good maintenance of the anterior chamber and the capsular bag.
INDICATIONS
Cataract extraction
Intraocular lens (IOL) implantation
Corneal transplantation surgery
Glaucoma filtering surgery
Surgical procedures to reattach the retina
PRECAUTIONS AND SIDE EFFECTS
The normal precautions associated with anterior segment and retinal attachment surgeries
should be, observed to avoid intra-and/or postoperative increase in intraocular pressure (IOP).
AUROgel should be removed by irrigation/aspiration at the end of the procedure. Clinical trials
have shown that AUROgel did not cause clinically significant elevation in IOP if some product
remained in situ after the surgery.
BIOCOMPATIBILITY
Result of acute, sub-acute and chronic toxicity studies together with the result of fertility,
peri-and post-natal toxicity studies show that sodium hyaluronate is well tolerated.
SUPPLY
Sterile I ml pre-filled glass syringes
STORAGE
Store at room temperature below 30 C
For better performance store between 2 C – 8 C (35 -47 F)
Refrigerated should be kept at room temperature for 15 minutes before use.
|
